Electronic Toxicity Monitoring and Patient-Reported Outcomes
- 1 July 2011
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 17 (4), 231-234
- https://doi.org/10.1097/ppo.0b013e31822c28b3
Abstract
Understanding the potential profile of adverse events associated with cancer treatment is essential in balancing safety versus benefits. Multiple stakeholders make use of this information for decision making, including patients, clinicians, researchers, regulators, and payors. Currently, adverse events are reported by clinical research staff, yet evidence suggests that this may contribute to underreporting of symptom events. Direct patient reporting via electronic interfaces offers a promising mechanism to enhance the efficiency and precision of our current approach and may complement clinician reports of adverse events. The National Cancer Institute has contracted to develop and test an item bank and software system for directly eliciting adverse symptom event information from patients in cancer clinical research, called the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events. The validity, usability, and scalability of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events prototype are currently being examined in academic and community-based settings.Keywords
This publication has 9 references indexed in Scilit:
- A Quantitative Analysis of Adverse Events and “Overwarning” in Drug LabelingArchives of Internal Medicine, 2011
- Supporting Clinical Practice Decisions With Real-Time Patient-Reported OutcomesJournal of Clinical Oncology, 2011
- The Missing Voice of Patients in Drug-Safety ReportingNew England Journal of Medicine, 2010
- Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical OutcomesJNCI Journal of the National Cancer Institute, 2009
- Agreement between patient-reported symptoms and their documentation in the medical record.2008
- Is There Room for Improvement in Adverse Event Reporting in the Era of Targeted Therapies?JNCI Journal of the National Cancer Institute, 2008
- Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving ForwardJournal of Clinical Oncology, 2007
- Patient-Reported Outcomes and the Evolution of Adverse Event Reporting in OncologyJournal of Clinical Oncology, 2007
- How Accurate Is Clinician Reporting of Chemotherapy Adverse Effects? A Comparison With Patient-Reported Symptoms From the Quality-of-Life Questionnaire C30Journal of Clinical Oncology, 2004